Anastrozole
Price | USD1.00 |
Packge | 1KG |
- Min. Order:1G
- Supply Ability:100KG
- Time:2019-07-06
Product Details
- Product NameAnastrozole
- CAS No.120511-73-1
- EINECS No.601-715-6
- MFC17H19N5
- MW293.37
- AppearancesolidWhite to off-white
- Melting point 81-82°C
- storage temp. room temp
- Boiling point 469.7±55.0 °C(Predicted)
- density 1.08±0.1 g/cm3(Predicted)
AD68
Anastrozole Basic information |
Product Name: | Anastrozole |
Synonyms: | ICI-D-1033;ARIMIDEX;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;ANASTROZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha’,alpha’-tetramethyl-5-(1h-1,2,4-t |
CAS: | 120511-73-1 |
MF: | C17H19N5 |
MW: | 293.36626 |
EINECS: | 1806241-263-5 |
Product Categories: | Active Pharmaceutical Ingredients;Antineoplastic;All Inhibitors;anti-neoplastic;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Anastrozole;API |
Mol File: | 120511-73-1.mol |
Anastrozole Chemical Properties |
Melting point | 81-82°C |
storage temp. | Store at RT |
solubility | DMSO: soluble40mg/mL |
InChIKey | YBBLVLTVTVSKRW-UHFFFAOYSA-N |
CAS DataBase Reference | 120511-73-1(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi,Xn |
Risk Statements | 36/37/38-22-61-60 |
Safety Statements | 26-37/39 |
RIDADR | 3249 |
RTECS | CZ1465000 |
HazardClass | 6.1(b) |
PackingGroup | III |
HS Code | 29339980 |
Hazardous Substances Data | 120511-73-1(Hazardous Substances Data) |
Anastrozole Usage And Synthesis |
Indications and Usage | Anastrozole is a potent selective triazole aromatase inhibitor that inhibits the aromatase that cytochrome P-450 is dependent on to prevent the biosynthesis of estrogen. Estrogen is the main stimulating factor for breast cancer cell growth. This drug’s half maximal inhibitory concentration (IC50) value to human placental aromatase is 15nmol/L. Compared to the traditional drug tamoxifen, Anastrozole can comprehensively and effectively lower the risks of breast cancer recurrence and metastasis, thus extending patients’ disease-free survival. Anastrozole is suitable for treating postmenopausal advanced breast cancer patients, especially postmenopausal advanced breast cancer patients who experienced recurrence following hormone assisted therapy. |
Clinical Research | A series of clinical trials compared the effects of third generation aromatase inhibitor Anastrozole with those of tamoxifen. The trial was a global multicenter trial and includes 381 centers in 21 countries. Since 1996, there have been 9366 patients who have participated, and the follow-up time is 100 months. 25.8% of patients in the Anastrozole group experienced recurrence, while 29.9% of patients in the tamoxifen group did. Thus, Anastrozole’s recurrence rate was 4.1% lower than that of tamoxifen, and its risk of distant metastasis was lower as well. Anastrozole is also safer than tamoxifen. |
Chemical Properties | Crystalline Solid |
Uses | antiseptic, spermaticide |
Uses | An aromatase inhibitor. Used as an antineoplastic. |
Definition | ChEBI: A 1,2,4-triazole compound having a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position. |
Biological Activity | Potent and highly selective aromatase (CYP19) inhibitor (IC 50 = 15nM) that has no discernible effect on adrenocorticoid hormone synthesis. Reduces plasma estrogen levels and exhibits antitumor activity in vivo . Orally active. |
Company Profile Introduction
Henan CoreyChem Co., Ltd, based on the original Zhengzhou Cote Chemical Research Institute, be brave in absorbing highly educated talents & overseas returnees; actively responded to Zhengzhou City High-tech Zone Government’s Special Care Policy, reorganized and founded in National University of Science and Technology Park, which is a high-tech, stock enterprise of high-end chemical Custom synthesis;The park was created by the People's Government of Henan Province, and proved by Ministry of Education and the National Science & Technology, taking the construction mode of "many college a park, and common development", mainly depends on Zhengzhou University and Henan University’s scientific research and talent advantage to set up Universities, scientific research institute and enterprise scientific research achievements transformation platform, to make high-tech enterprises incubate, is the new high-tech talent gathering base, high and new technology industry enterprise radiation base, colleges and universities technological innovation base.
Henan Coreychem Co., Ltd, facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 120511-73-1 ANASTROZOLE 95-99 %
- Inquiry
- 2024-09-11
-
VIP1年
- Akums Lifesciences Ltd
- 120511-73-1 Anastrozole 99%
- Inquiry
- 2024-03-29
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- 120511-73-1 Anastrozole 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Fresenius Kabi Oncology Limited
- Anastrozole 120511-73-1 98%
- Inquiry
- 2024-03-14
-
VIP1年
- Khandelwal Laboratories Private Limited
- Anastrozole 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Shreyaa Medilife Private Limited
- 120511-73-1 98%
- Inquiry
- 2024-03-04
-
VIP1年
- Mac Chem Products (India) Pvt Ltd (Naprod Group)
- 120511-73-1 Anastrozole 98%
- Inquiry
- 2024-02-28
-
VIP1年
- Beta Drugs
- Anastrozole 120511-73-1 98%
- Inquiry
- 2024-02-26
-
VIP1年
- Ind Swift Laboratories Ltd
- 120511-73-1 99%
- Inquiry
- 2024-02-24
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- 120511-73-1 Anastrozole 98%
- Inquiry
- 2024-02-24
- Since:2014-12-17
- Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY